Home / Fact sheets / Population fact sheet

Country fact sheet: Libya

Population

- Total population: 6 293 253
- Female population: 3 118 968
- Male population: 3 174 285
The World Bank (2016)

Health Expenditure

- Total per capita (US$): 0.0
- Out-of-pocket (% of total expenditure on health): 0.0
World Health Organization (2015)

Human Development Index

- HDI: 0.716
- Category: High
UNDP Human Development Report (2015)

Geography

Life Expectancy at Birth

- Total population (years): 71.9
- Female population (years): 74.9
- Male population (years): 69.2
The World Bank (2016)

Cancer Burden

- Overall cancer incidence (rate per 100 000 persons per year): 120.3
- Overall cancer mortality (rate per 100 000 persons per year): 69.1
- Most common cancer site by incidence for females (rate per 100 000 persons per year): Breast (23.2)
- Most common cancer site by mortality for females (rate per 100 000 persons per year):  (7.6)
- Most common cancer site by incidence for males (rate per 100 000 persons per year):  (26.4)
- Most common cancer site by mortality for males (rate per 100 000 persons per year): Lung (23.0)
- GLOBOCAN 2018 population fact sheet
GLOBOCAN (2018)

BREAST CANCER SCREENING PROGRAMME

Last updated year for qualitative data: No data available currently
Source of data: No source
Last updated year for quantitative data: No data available currently
Source of data: No source

Screening protocol

Year published/updated:
Screening test used:
Target age (min-max) and screening interval [months] for each test:

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy:
Program introduction was preceded by a pilot:
Year program was initiated:
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme:
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with Population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals:
Source of population data:
Annual target for screening coverage:
Invitations to eligible population:
Method of invitation:
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme:
Current status of implementation (applicable only for population-based programmes):
Cancer screening programme population based for selected populations:

Performance indicators

Target age and regional limitation if applicable:
Invitation coverage (%):
Examination coverage (%):
Participation rate (%):
Completeness of data related to screening results (%):
Completeness of data related to further assessment results (%):
Further assessment rate (%):
Further assessment participation rate (%):
Detection rate of CIS and invasive (x 1000):
Detection rate of invasive cancer (x 1000):
Positive predictive value of further assessment to detect CIS and invasive (%):
Proportion of total carcinomas which are CIS (%):
Benign surgical biopsy rate (x 1000):



CERVICAL CANCER SCREENING PROGRAMME

Last updated year for qualitative data: No data available currently
Source of data: No source
Last updated year for quantitative data: No data available currently
Source of data: No source

Screening protocol

Year published/updated:
Screening test used:
Target age (min-max) and screening interval [months] for each test:
Triaging test used:
"screen and treat" included in the protocol:

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy:
Program introduction was preceded by a pilot:
Year program was initiated:
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme:
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals:
Source of population data:
Annual target for screening coverage:
Invitations to eligible population:
Screening kit included with the invitation:
Method of invitation:
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme:
Current status of implementation:
Cancer screening programme population based for selected populations/regions:

Performance indicators

Target age and regional limitation if applicable:
Invitation coverage (%):
Examination coverage (invitation cohort) (%):
Examination coverage (tests in the index-year) (%):
Participation rate (%):
Completeness of data related to screening test results (%):
Completeness of data related to further assessment results (%):
Colposcopy referral rate (%):
Colposcopy participation rate (%):
Detection rate of CIN2+ (x 1000):
Detection rate of CIN3+ (x 1000):
Positive Predictive Value of abnormal screening test to detect CIN2+ (x 1000):
Positive Predictive Value of CIN3+ (x 1000):



COLORECTAL CANCER SCREENING PROGRAMME

Last updated year for qualitative data: No data available currently
Source of data: No source
Last updated year for quantitative data: No data available currently
Source of data: No source

Screening protocol

Year published/updated:
Screening test used:
Target age (min-max) and screening interval [months] for each test:

Programme status and organization

Dedicated person/team to coordinate the programme:                   
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy:
Program introduction was preceded by a pilot:
Year program was initiated:
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme:
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals:
Source of population data:
Annual target for screening coverage:
Invitations to eligible population:
Method of invitation:
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme:
Current status of implementation (applicable only for population-based programmes):
Cancer screening programme population based for selected populations:

Performance indicators

FIT gFOBT sigmoidoscopy Colonoscopy
Target age and regional limitation if applicable:
Invitation coverage (%):
Examination coverage (%):
Participation rate (%):
Completeness of data related to screening results (%):
Completeness of data related to information about attendance to colonoscopy assessment (%):
Completeness of data related to histology result (%):
Screen positivity (indication for follow-up colonoscopy) rate (%) :
Follow-up colonoscopy participation rate (%):
Completion rate follow-up colonoscopy (%):
Detection rate of adenomas (x 1000):
Detection rate of advanced adenomas (x 1000):
Detection rate of colorectal cancers (x 1000):
Positive Predictive Value of further assessment to detect adenomas (%):
Positive Predictive Value of further assessment to detect advanced adenomas (%):
Positive Predictive Value of further assessment to detect colorectal cancers (%):